E-LIB Suche - Ergebnisse für: Haal, S

1

Adipose Tissue, Bile Acids, and Gut Microbiome Species Asso..:

Guman, M.S.S. ; Hoozemans, J.B. ; Haal, S....
Journal of Lipid Research. 63 (2022) 11 - p. 100280 , 2022

Link: https://doi.org/10.1016/..

2

Adipose Tissue, Bile Acids, and Gut Microbiome Species Asso..:

Guman, M.S.S ; Hoozemans, J.B ; Haal, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672443/. , 2022

Link: http://www.ncbi.nlm.nih...

3

The Australasian COVID-19 Trial (ASCOT) to assess clinical ..:

Denholm, JT ; Davis, J ; Paterson, D...
The original publication is available from Springer - https://doi.org/10.1186/s13063-020-04576-9 - http://dx.doi.org/10.1186/s13063-020-04576-9. , 2020

Link: https://hdl.handle.net/1..

4

Adipose Tissue, Bile Acids, and Gut Microbiome Species Asso..:

M.S.S. Guman ; J.B. Hoozemans ; S. Haal...
http://www.sciencedirect.com/science/article/pii/S0022227522001134. , 2022

Link: https://doi.org/10.1016/..

5

Ursodeoxycholic Acid Use After Bariatric Surgery: Effects o..:

Guman, Maimoena S. S. ; Haal, Sylke ; Acherman, Yair I. Z....
Obesity Surgery. 33 (2023) 6 - p. 1773-1781 , 2023

Link: https://doi.org/10.1007/..

6

Cost-effectiveness of ursodeoxycholic acid in preventing ne..:

Haal, Sylke ; Guman, Maimoena S S ; de Brauw, L Maurits...
British Journal of Surgery. 109 (2022) 11 - p. 1116-1123 , 2022

Link: https://doi.org/10.1093/..

7

Risk Factors for Symptomatic Gallstone Disease and Gallston..:

Haal, Sylke ; Guman, Maimoena S. S. ; Bruin, Sjoerd...
Obesity Surgery. 32 (2022) 4 - p. 1270-1278 , 2022

Link: https://doi.org/10.1007/..

8

Gallstone Formation Follows a Different Trajectory in Baria..:

Haal, Sylke ; Guman, Maimoena S. S. ; Acherman, Yair I. Z....
Metabolites. 11 (2021) 10 - p. 682 , 2021

Link: https://doi.org/10.3390/..

9

Ursodeoxycholic acid for the prevention of symptomatic gall..:

Haal, Sylke ; Guman, Maimoena S. S. ; de Brauw, L. Maurits...
Trials. 21 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

10

Gallstone Formation Follows a Different Trajectory in Baria..:

Haal, Sylke ; Guman, Maimoena S. S ; Acherman, Yair I. Z...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541369/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Ursodeoxycholic acid for the prevention of symptomatic gall..:

Haal, Sylke ; Guman, Maimoena S. S ; de Brauw, L. Maurits...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376318/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Gallstone Formation Follows a Different Trajectory in Baria..:

Sylke Haal ; Maimoena S. S. Guman ; Yair I. Z. Acherman...
https://www.mdpi.com/2218-1989/11/10/682. , 2021

Link: https://doi.org/10.3390/..

13

Gallstone Formation Follows a Different Trajectory in Baria..:

Sylke Haal ; Maimoena S. S. Guman ; Yair I. Z. Acherman...
Endocrinology and Clinical Metabolic Research. , 2021

Link: https://doi.org/10.3390/..

14

Ursodeoxycholic acid for the prevention of symptomatic gall..:

Sylke Haal ; Maimoena S. S. Guman ; L. Maurits de Brauw...
http://link.springer.com/article/10.1186/s13063-020-04605-7. , 2020

Link: https://doi.org/10.1186/..